Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$396K Buy
3,078
+216
+8% +$25.3K 0.11% 67
2026
Q1
$344K Buy
2,862
+84
+3% +$9.7K 0.11% 64
2025
Q4
$292K Sell
2,778
-283
-9% -$26.6K 0.09% 68
2025
Q3
$257K Buy
+3,061
New +$252K 0.08% 77

Other funds holding MRK

Whelan Financial's MRK Position: Q2 2026 in Review

Whelan Financial increased its Merck (MRK) stake by 7.5% in Q2 2026, buying an estimated $25.3K and bringing the position to 3,078 shares worth $396K. The position accounts for 0.11% of the portfolio, ranked #67.

Whelan Financial first reported a position in MRK in Q3 2025 and has held it in 4 quarters since. 1,699 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Whelan Financial held 3,078 shares of Merck worth $396K as of Q2 2026.
  • Whelan Financial bought 216 Merck shares in Q2 2026, an estimated $25.3K.
  • Merck made up 0.11% of Whelan Financial's portfolio in Q2 2026, its #67 holding.
  • Whelan Financial first reported a position in Merck in Q3 2025 and has held it in 4 quarters since.
  • 1,699 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Whelan Financial's 13F filing for Q2 2026, filed 24 Jul 2026.